Abstract: To visualize planned behavior of an autonomous vehicle (AV) traveling along a roadway, a user interface engine receives data describing a planned pathway of the AV along the roadway and object data describing an object having a predicted pathway crossing the planned pathway of the AV at a cross point. The user interface engine classifies the object either an asserting object or a yielding object based on a prediction of whether the object reaches the cross point before the AV or after the AV. The user interface engine generates an image that includes the planned pathway of the AV and the object in the environment of the AV. The image of the object indicates whether the object is classified as an asserting object or a yielding object.

Abstract: Provided herein are immune cells and methods of use, wherein the immune cells include a chimeric antigen receptor (CAR), wherein the CAR comprises an extracellular antigen binding domain that binds specifically to a first epitope; and an inhibitory chimeric antigen receptor (iCAR), wherein the iCAR comprises an extracellular antigen binding domain that binds specifically to a second epitope, wherein the immune cell is activated when the immune cells binds to the first epitope and does not bind to the second epitope; and wherein the immune cell is inactivated when the immune cell binds to the first and second epitopes.

Abstract: Systems and methods involving nanomaterial-based electrodes, such as supercapacitor and battery electrodes that can be flexible, are described.

Abstract: This document relates to methods and materials for treating T cell cancers. For example, a composition containing one or more bispecific molecules targeting T cell receptor £ chain constant region (TRBC) can be administered to a mammal having a T cell cancer to treat the mammal. For example, this document provides methods and materials for using one or more bispecific molecules to treat a mammal having a T cell cancer.

Abstract: The invention provides immunoconjugates of Formula I comprising an anti-HER2 antibody linked by conjugation to one or more 8-Het-2-aminobenzazepine derivatives. The invention also provides 8-Het-2-aminobenzazepine derivative intermediate compositions comprising a reactive functional group. Such intermediate compositions are suitable substrates for formation of the immunoconjugates through a linker or linking moiety. The invention further provides methods of treating cancer with the immunoconjugates.

Abstract: Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Abstract: This disclosure describes systems, devices, apparatus, and methods, including computer programs encoded on storage media, for controlling a network with one or more access points (APs). A controller may be configured to schedule at least some resources of the one or more APs to improve network efficiency. The APs may measure and report a variety of information and statistics to the controller. The controller may determine one or more transmission parameters and one or more operations a given AP is permitted to perform during a respective time interval. The controller may communicate the one or more transmission parameters using an indication, such as a message. At least one AP associated with the controller may communicate with stations (STAs) using the one or more transmission parameters.

Abstract: A method for patterning a layer increases the density of features formed over an initial patterning layer using a series of self-aligned spacers. A layer to be etched is provided, then an initial sacrificial patterning layer, for example formed using optical lithography, is formed over the layer to be etched. Depending on the embodiment, the patterning layer may be trimmed, then a series of spacer layers formed and etched. The number of spacer layers and their target dimensions depends on the desired increase in feature density. An in-process semiconductor device and electronic system is also described.

Abstract: Polymeric electro spray emitters and related methods are generally described. In some embodiments, an emitter may be made from an ionic electro active polymer. The composition of the electro spray emitters described herein may enable the transport of ions and/or liquid ion sources, such as an ionic liquid or room temperature molten salt, through the bulk of the polymeric emitter. In some embodiments, the described emitters may be fabricated using a mixture of an ionic electroactive polymer, a solvent, and a liquid ion source to at least partially mitigate swelling effects of the polymer emitter that may otherwise occur when the one or more emitters are exposed to the liquid ion source during operation.

Abstract: A circuit interrupter including a current sensor having a normal sensor output and an over current detection output, a solid state switch module structured to have a closed state to allow current to flow through the circuit interrupter and an open state to interrupt current flowing through the circuit interrupter, a gate driver structured to control the solid state switch module including a desaturation function output, wherein the gate driver is structured to cause the solid state switch module to interrupt current flowing through the circuit interrupter when the DESAT function output changes to the on state, and an electronic trip circuit structured to output a trip signal to the gate driver when the normal sensor output reaches a first threshold level or the overcurrent detection output changes to the on state.

Abstract: In certain embodiments, dynamic content presentation related to a personalized care plan may be facilitated. In some embodiments, content presentation of a content session set may be initiated for an individual in accordance with a care plan associated with the individual, where the care plan specifies a presentation order for content sessions of the content session set. A time period (during which the individual is unavailable to receive presentation of a content session) may be determined. The presentation order for after the time period may be updated based on (i) the determination of the time period and (ii) a prioritization scheme by which content sessions of the content session set is to be prioritized. The content presentation for the individual may be resumed based on the updated presentation order such that the content presentation after the time period accounts for content sessions assigned to be presented during the time period.

Abstract: A care plan management system (10) includes storage (16) containing (i) care management-related content (14) and (ii) a patient care plan (21, 22, 23) including at least a schedule for presenting selected care management-related content. A user interface (31, 32, 33) is configured to receive and present care management-related content. At least one processor (26, 44) communicates with the storage and the user interface. The at least one processor is configured to communicate care management-related content to the user interface in accordance with the patient care plan and to automatically adjust the schedule of the patient care plan to free up a selected time period (54).

Abstract: A care plan management system (10) includes storage (16) containing (i) care management-related content (14) and (ii) a patient care plan (21, 22, 23) including at least a schedule for presenting selected care management-related content. A user interface (31, 32, 33) is configured to receive and present care management-related content. At least one processor (26, 44) communicates with the storage and the user interface. The at least one processor is configured to communicate care management-related content to the user interface in accordance with the patient care plan and to automatically adjust the schedule of the patient care plan to free up a selected time period (54).

Abstract: A health management system (10) comprises a user interface (48) which enables an entry of a patient identification. An association device or means (130, 152) associates the biometric data acquired by medical monitoring devices (821, 822, . . . ) with the entered patient identification.

Abstract: A patient information system and method are described. The system provides patient interaction via a display.

Abstract: A patient interaction apparatus 10 includes a medical server 13 that generates a reflexive survey as a result of items of interest (such as abnormal or unexpected vital signs) in objective or subjective data reported from a patient interface device 11. The survey of the present invention reacts to objective results with the intent of probing into the patient's current condition. The patient survey of the present invention specifically probes why a patient's weight, blood pressure, or pulse rate, to name only a few examples, may be higher than expected. Various methods for determining the trigger conditions and the elimination of erroneously reported vital signs are set forth.